Showing results (41-50 of 134) with videos related to

Sort By:
Pageof 14
Antimicrobial Agents and Chemotherapy|September 29, 2005
Antistaphylococcal activity of ceftobiprole, a new broad-spectrum cephalosporinTatiana Bogdanovich, Lois M Ednie, Stuart Shapiro, et al.
Antimicrobial Agents and Chemotherapy|January 28, 2005
Antistaphylococcal activity of dalbavancin, an experimental glycopeptideGengrong Lin, Kim Credito, Lois M Ednie, et al.
Antimicrobial Agents and Chemotherapy|March 25, 2009
Comparative antipneumococcal activities of sulopenem and other drugsKlaudia Kosowska-Shick, Lois M Ednie, Pamela McGhee, et al.
Antimicrobial Agents and Chemotherapy|February 18, 2010
Antistaphylococcal activities of telavancin tested alone and in combination by time-kill assayGengrong Lin, Glenn A Pankuch, Lois M Ednie, et al.
The Journal of Antimicrobial Chemotherapy|July 3, 2010
Spiral gradient endpoint susceptibility testing: a fresh look at a neglected techniqueRocky Pong, Maureen V Boost, Margaret M O'Donoghue, et al.
Antimicrobial Agents and Chemotherapy|November 25, 2004
Derivatives of a vancomycin-resistant Staphylococcus aureus strain isolated at Hershey Medical CenterBülent Bozdogan, Lois Ednie, Kim Credito, et al.
The Journal of Antimicrobial Chemotherapy|September 18, 2009
Cellular pharmacokinetics and intracellular activity of torezolid (TR-700): studies with human macrophage (THP-1) and endothelial (HUVEC) cell linesSandrine Lemaire, Françoise Van Bambeke, Peter C Appelbaum, et al.
Diagnostic Microbiology and Infectious Disease|May 12, 2012
Activity of telavancin compared to other agents against coagulase-negative staphylococci with different resistotypes by time killGengrong Lin, Glenn A Pankuch, Peter C Appelbaum, et al.
Pageof 14